| 2.6 |
2.6 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 2.3 |
7.0 |
GO:0014028 |
notochord formation(GO:0014028) |
| 1.9 |
5.7 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 1.7 |
3.3 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 1.4 |
4.2 |
GO:0021998 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
| 1.4 |
4.1 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 1.4 |
5.4 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 1.3 |
3.9 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 1.3 |
3.9 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.3 |
3.9 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 1.2 |
4.9 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 1.2 |
5.9 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 1.1 |
5.6 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 1.1 |
4.5 |
GO:0003360 |
brainstem development(GO:0003360) |
| 1.1 |
6.5 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 1.0 |
3.1 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 1.0 |
3.0 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 1.0 |
2.0 |
GO:2000977 |
regulation of forebrain neuron differentiation(GO:2000977) |
| 1.0 |
11.0 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 1.0 |
1.0 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 1.0 |
3.9 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 1.0 |
2.9 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 1.0 |
2.9 |
GO:0086047 |
membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 0.9 |
3.8 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) |
| 0.9 |
4.6 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 0.9 |
0.9 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.9 |
7.1 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.9 |
2.6 |
GO:1904719 |
excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.9 |
2.6 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.9 |
0.9 |
GO:0072012 |
renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) glomerulus vasculature development(GO:0072012) |
| 0.9 |
2.6 |
GO:1904395 |
positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.9 |
5.2 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.8 |
2.5 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.8 |
2.5 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.8 |
3.3 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.8 |
0.8 |
GO:1904393 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
| 0.8 |
2.4 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.8 |
2.4 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.8 |
2.3 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.8 |
2.3 |
GO:0045819 |
plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
| 0.8 |
4.6 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.8 |
2.3 |
GO:0030421 |
defecation(GO:0030421) |
| 0.8 |
3.0 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) mitral valve formation(GO:0003192) |
| 0.8 |
3.0 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.7 |
3.0 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.7 |
1.5 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.7 |
2.2 |
GO:0035878 |
nail development(GO:0035878) |
| 0.7 |
0.7 |
GO:2000850 |
negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.7 |
1.4 |
GO:0038044 |
transforming growth factor-beta secretion(GO:0038044) |
| 0.7 |
2.2 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.7 |
0.7 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 0.7 |
2.2 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.7 |
2.1 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.7 |
2.1 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.7 |
3.5 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.7 |
2.8 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.7 |
1.4 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.7 |
2.1 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.7 |
7.5 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.7 |
5.5 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.7 |
2.0 |
GO:0021972 |
corticospinal neuron axon guidance(GO:0021966) corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.7 |
3.3 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.7 |
3.3 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.7 |
0.7 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.7 |
1.3 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.7 |
0.7 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.7 |
2.6 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
| 0.7 |
6.5 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.6 |
1.9 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.6 |
0.6 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) |
| 0.6 |
1.9 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.6 |
2.4 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.6 |
0.6 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.6 |
0.6 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.6 |
0.6 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.6 |
2.4 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 0.6 |
4.0 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.6 |
5.2 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.6 |
4.0 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.6 |
1.1 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.6 |
1.7 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.6 |
1.7 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.6 |
1.1 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
| 0.6 |
0.6 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 0.6 |
0.6 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.6 |
2.2 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.6 |
4.4 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.5 |
0.5 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.5 |
1.6 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.5 |
3.3 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 0.5 |
2.2 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.5 |
0.5 |
GO:0032760 |
positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
| 0.5 |
0.5 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.5 |
1.6 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.5 |
1.6 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.5 |
2.7 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.5 |
5.8 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.5 |
1.1 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 0.5 |
2.1 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.5 |
3.1 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.5 |
2.1 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.5 |
2.6 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.5 |
1.0 |
GO:0021937 |
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.5 |
2.0 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.5 |
1.5 |
GO:2000510 |
positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.5 |
2.0 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.5 |
1.0 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.5 |
2.0 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.5 |
2.5 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.5 |
1.5 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.5 |
1.5 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.5 |
1.5 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.5 |
2.0 |
GO:0060857 |
establishment of glial blood-brain barrier(GO:0060857) |
| 0.5 |
1.0 |
GO:0034137 |
positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
| 0.5 |
2.9 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.5 |
1.5 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.5 |
1.9 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.5 |
1.5 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.5 |
4.8 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.5 |
0.5 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) |
| 0.5 |
1.4 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.5 |
1.0 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.5 |
0.9 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.5 |
1.4 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.5 |
4.2 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.5 |
0.5 |
GO:1904672 |
regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.5 |
3.3 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.5 |
1.4 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.5 |
2.3 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.5 |
0.5 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.5 |
1.8 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.5 |
1.8 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.4 |
4.0 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.4 |
0.4 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.4 |
1.8 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.4 |
1.3 |
GO:0000448 |
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.4 |
1.3 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.4 |
0.4 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.4 |
1.3 |
GO:0019659 |
fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.4 |
0.4 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 0.4 |
1.3 |
GO:1990859 |
cellular response to endothelin(GO:1990859) |
| 0.4 |
1.8 |
GO:2000054 |
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 0.4 |
1.7 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.4 |
0.9 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.4 |
1.7 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.4 |
2.1 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.4 |
1.7 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.4 |
0.9 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.4 |
2.1 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.4 |
1.7 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.4 |
0.8 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 0.4 |
1.3 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 0.4 |
3.4 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.4 |
1.3 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.4 |
1.7 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 |
0.4 |
GO:0009880 |
embryonic pattern specification(GO:0009880) |
| 0.4 |
1.6 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.4 |
0.8 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.4 |
2.9 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.4 |
0.8 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.4 |
1.2 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 0.4 |
1.6 |
GO:0090132 |
tissue migration(GO:0090130) epithelium migration(GO:0090132) |
| 0.4 |
1.2 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.4 |
0.4 |
GO:0022612 |
gland morphogenesis(GO:0022612) |
| 0.4 |
4.0 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.4 |
5.6 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.4 |
0.8 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.4 |
1.2 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.4 |
2.0 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.4 |
2.4 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.4 |
0.8 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.4 |
0.4 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.4 |
3.1 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.4 |
2.3 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.4 |
0.4 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.4 |
1.9 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.4 |
0.4 |
GO:0051450 |
myoblast proliferation(GO:0051450) regulation of myoblast proliferation(GO:2000291) |
| 0.4 |
2.3 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.4 |
6.1 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.4 |
1.1 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.4 |
1.9 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.4 |
1.1 |
GO:0060217 |
hemangioblast cell differentiation(GO:0060217) regulation of mast cell differentiation(GO:0060375) |
| 0.4 |
6.4 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.4 |
1.1 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.4 |
0.4 |
GO:0072069 |
DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.4 |
1.1 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.4 |
0.4 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.4 |
2.3 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.4 |
2.6 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.4 |
1.1 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.4 |
2.2 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.4 |
0.7 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.4 |
1.1 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.4 |
1.1 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.4 |
8.9 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.4 |
2.6 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.4 |
0.4 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.4 |
1.1 |
GO:0090004 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.4 |
1.5 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.4 |
0.4 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.4 |
1.5 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.4 |
1.1 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.4 |
1.1 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.4 |
1.1 |
GO:0060558 |
regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
| 0.4 |
0.7 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.4 |
1.1 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.4 |
5.4 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.4 |
2.5 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.4 |
0.4 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.4 |
1.1 |
GO:0046655 |
folic acid metabolic process(GO:0046655) |
| 0.4 |
5.6 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.4 |
1.1 |
GO:0019062 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.4 |
1.4 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.4 |
2.5 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.3 |
1.0 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.3 |
1.0 |
GO:1905075 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) epicardium morphogenesis(GO:1905223) |
| 0.3 |
3.1 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.3 |
2.1 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.3 |
2.1 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.3 |
1.0 |
GO:1904975 |
response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.3 |
1.4 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.3 |
9.9 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.3 |
0.7 |
GO:0071707 |
immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.3 |
1.0 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.3 |
1.0 |
GO:1901675 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.3 |
1.3 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.3 |
0.7 |
GO:0010877 |
lipid transport involved in lipid storage(GO:0010877) |
| 0.3 |
4.7 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.3 |
2.0 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.3 |
1.0 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.3 |
0.3 |
GO:0090259 |
regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.3 |
1.0 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.3 |
2.0 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.3 |
1.0 |
GO:0048698 |
regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.3 |
1.3 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 |
3.5 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.3 |
2.2 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.3 |
1.0 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.3 |
1.0 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.3 |
0.9 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.3 |
1.3 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.3 |
1.9 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.3 |
1.2 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.3 |
0.3 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.3 |
0.9 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.3 |
1.2 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.3 |
2.4 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.3 |
1.8 |
GO:0036490 |
regulation of translation in response to endoplasmic reticulum stress(GO:0036490) |
| 0.3 |
1.8 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.3 |
1.2 |
GO:0060709 |
glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
| 0.3 |
3.0 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.3 |
1.5 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.3 |
0.3 |
GO:0051791 |
medium-chain fatty acid metabolic process(GO:0051791) |
| 0.3 |
0.9 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.3 |
0.9 |
GO:0042823 |
pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.3 |
2.1 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.3 |
1.2 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.3 |
0.3 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.3 |
0.6 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.3 |
0.9 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.3 |
2.6 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.3 |
1.5 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.3 |
0.3 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) |
| 0.3 |
0.6 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.3 |
0.6 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.3 |
0.6 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 |
2.0 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.3 |
4.3 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.3 |
1.4 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.3 |
0.6 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.3 |
1.1 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.3 |
1.7 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.3 |
0.6 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.3 |
0.8 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.3 |
1.4 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.3 |
1.7 |
GO:1902946 |
protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.3 |
0.6 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.3 |
1.1 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.3 |
1.7 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.3 |
0.8 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.3 |
2.5 |
GO:2000645 |
negative regulation of receptor catabolic process(GO:2000645) |
| 0.3 |
0.3 |
GO:0022028 |
tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
| 0.3 |
3.6 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.3 |
3.9 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.3 |
1.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.3 |
0.3 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.3 |
0.5 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.3 |
3.8 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.3 |
0.8 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.3 |
3.3 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.3 |
3.0 |
GO:0006085 |
acetyl-CoA biosynthetic process(GO:0006085) |
| 0.3 |
3.0 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.3 |
0.3 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.3 |
1.1 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.3 |
1.3 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.3 |
1.1 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.3 |
1.6 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.3 |
1.6 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 0.3 |
0.5 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.3 |
0.3 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.3 |
2.4 |
GO:1904152 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.3 |
0.3 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.3 |
1.3 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.3 |
1.1 |
GO:0035937 |
estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.3 |
0.8 |
GO:2000659 |
regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.3 |
0.3 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.3 |
0.8 |
GO:0051316 |
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
| 0.3 |
0.3 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.3 |
1.3 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.3 |
0.8 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.3 |
0.5 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.3 |
1.5 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.3 |
0.3 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.3 |
0.8 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 0.3 |
0.5 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 |
2.3 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.3 |
0.5 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.3 |
1.5 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.3 |
0.3 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.3 |
0.3 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.3 |
2.0 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 |
4.0 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.3 |
0.3 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.3 |
1.3 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.2 |
1.2 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.2 |
0.2 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.2 |
0.7 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 0.2 |
7.0 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.2 |
2.2 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.2 |
0.2 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.2 |
0.2 |
GO:0048333 |
mesodermal cell differentiation(GO:0048333) |
| 0.2 |
0.2 |
GO:1901836 |
regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
| 0.2 |
0.5 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.2 |
4.9 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.2 |
3.0 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.2 |
1.2 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 |
2.5 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.2 |
0.2 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.2 |
0.2 |
GO:0061013 |
regulation of mRNA catabolic process(GO:0061013) positive regulation of mRNA catabolic process(GO:0061014) |
| 0.2 |
0.2 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.2 |
2.9 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.2 |
1.9 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.2 |
0.2 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 |
2.4 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.2 |
4.6 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
0.2 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.2 |
2.2 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.2 |
2.2 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
0.7 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.2 |
1.9 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.2 |
0.5 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.2 |
0.7 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.2 |
0.5 |
GO:1904796 |
regulation of core promoter binding(GO:1904796) |
| 0.2 |
1.2 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.2 |
0.7 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.2 |
0.5 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.2 |
1.6 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.2 |
1.6 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.2 |
1.6 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.2 |
0.5 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 |
0.2 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 |
2.1 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
0.7 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.2 |
0.9 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.2 |
0.5 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.2 |
0.2 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.2 |
1.1 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.2 |
0.2 |
GO:0006551 |
leucine metabolic process(GO:0006551) |
| 0.2 |
0.4 |
GO:1901990 |
regulation of mitotic cell cycle phase transition(GO:1901990) |
| 0.2 |
2.9 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.2 |
2.4 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.2 |
0.7 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.2 |
0.2 |
GO:0010573 |
vascular endothelial growth factor production(GO:0010573) |
| 0.2 |
1.8 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.2 |
0.4 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 |
7.2 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.2 |
1.5 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.2 |
2.6 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
0.6 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.2 |
0.9 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 |
0.4 |
GO:0010424 |
DNA methylation on cytosine within a CG sequence(GO:0010424) |
| 0.2 |
1.1 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.2 |
2.3 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.2 |
1.1 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.2 |
0.6 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.2 |
0.6 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.2 |
0.6 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.2 |
0.4 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.2 |
0.4 |
GO:2000416 |
regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
| 0.2 |
0.2 |
GO:0035934 |
corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.2 |
1.0 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.2 |
0.2 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.2 |
1.6 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
0.8 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.2 |
2.5 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 |
0.4 |
GO:0043921 |
modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
| 0.2 |
0.2 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
| 0.2 |
5.1 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.2 |
0.2 |
GO:2000738 |
positive regulation of stem cell differentiation(GO:2000738) |
| 0.2 |
12.8 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.2 |
1.0 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 |
0.2 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.2 |
0.4 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
| 0.2 |
0.2 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.2 |
2.6 |
GO:0046036 |
CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.2 |
0.4 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.2 |
2.2 |
GO:0042772 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
| 0.2 |
0.6 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.2 |
0.6 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.2 |
0.4 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.2 |
0.2 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 |
0.8 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.2 |
0.2 |
GO:0034968 |
histone lysine methylation(GO:0034968) |
| 0.2 |
1.7 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.2 |
1.0 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.2 |
0.8 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.2 |
0.2 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.2 |
0.2 |
GO:0051155 |
positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.2 |
0.2 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.2 |
0.8 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.2 |
1.0 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.2 |
5.5 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.2 |
0.6 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.2 |
0.2 |
GO:0071599 |
otic vesicle development(GO:0071599) |
| 0.2 |
0.8 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.2 |
0.6 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.2 |
0.7 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.2 |
0.7 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.2 |
0.6 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.2 |
0.2 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) mitochondrial DNA metabolic process(GO:0032042) |
| 0.2 |
0.6 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.2 |
2.0 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.2 |
2.0 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.2 |
0.6 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.2 |
1.1 |
GO:0090005 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.2 |
0.7 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.2 |
0.4 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.2 |
0.6 |
GO:1904569 |
regulation of selenocysteine incorporation(GO:1904569) |
| 0.2 |
0.4 |
GO:0048636 |
positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 0.2 |
0.4 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.2 |
5.1 |
GO:0035567 |
non-canonical Wnt signaling pathway(GO:0035567) |
| 0.2 |
0.5 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.2 |
2.6 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.2 |
0.5 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.2 |
0.4 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.2 |
1.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.2 |
0.2 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.2 |
0.7 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.2 |
0.4 |
GO:0060231 |
mesenchymal to epithelial transition(GO:0060231) |
| 0.2 |
0.9 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.2 |
0.4 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 |
0.4 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 0.2 |
0.7 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.2 |
1.1 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.2 |
0.4 |
GO:0032493 |
response to bacterial lipoprotein(GO:0032493) |
| 0.2 |
1.1 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 |
0.9 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.2 |
0.7 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 |
0.7 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 |
1.2 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.2 |
0.7 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.2 |
1.7 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.2 |
0.3 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.2 |
0.3 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.2 |
0.5 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.2 |
1.9 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.2 |
2.4 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.2 |
0.5 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.2 |
0.7 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 0.2 |
1.5 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 |
5.1 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 |
1.2 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.2 |
0.5 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.2 |
1.0 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.2 |
1.5 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.2 |
1.2 |
GO:1902510 |
regulation of apoptotic DNA fragmentation(GO:1902510) |
| 0.2 |
1.5 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.2 |
0.5 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.2 |
1.8 |
GO:0045830 |
positive regulation of isotype switching(GO:0045830) |
| 0.2 |
0.5 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.2 |
4.8 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.2 |
0.3 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.2 |
0.7 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.2 |
1.7 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 |
0.5 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.2 |
0.3 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.2 |
0.7 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.2 |
1.0 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 |
1.8 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.2 |
0.5 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 |
0.2 |
GO:0035672 |
phospholipid efflux(GO:0033700) oligopeptide transmembrane transport(GO:0035672) |
| 0.2 |
0.6 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.2 |
0.5 |
GO:0072093 |
metanephric renal vesicle formation(GO:0072093) |
| 0.2 |
1.0 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 |
0.3 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.2 |
1.1 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.2 |
0.5 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.2 |
1.1 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.2 |
0.5 |
GO:0019389 |
glucuronoside metabolic process(GO:0019389) |
| 0.2 |
0.6 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 |
0.5 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.2 |
0.6 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.2 |
1.1 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.2 |
0.6 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.2 |
1.6 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.2 |
0.8 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.2 |
0.8 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.2 |
1.2 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.2 |
0.6 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.2 |
0.3 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.2 |
0.6 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.2 |
0.3 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 |
2.3 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
1.4 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.2 |
0.8 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
1.2 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 |
1.2 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.1 |
1.0 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 |
0.4 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.1 |
3.0 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.1 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
| 0.1 |
0.7 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.1 |
1.0 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
0.4 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.1 |
0.1 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.1 |
2.1 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.1 |
0.6 |
GO:0032309 |
icosanoid secretion(GO:0032309) |
| 0.1 |
0.3 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.1 |
0.4 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
0.1 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.1 |
2.3 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.1 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.1 |
1.5 |
GO:2000269 |
regulation of fibroblast apoptotic process(GO:2000269) |
| 0.1 |
0.9 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.1 |
0.1 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 |
0.4 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.1 |
0.6 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.1 |
0.6 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 |
1.3 |
GO:0060430 |
lung saccule development(GO:0060430) |
| 0.1 |
0.6 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.1 |
0.6 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
0.3 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) acetyl-CoA catabolic process(GO:0046356) |
| 0.1 |
0.6 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.1 |
0.1 |
GO:0060442 |
branching involved in prostate gland morphogenesis(GO:0060442) |
| 0.1 |
0.1 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.1 |
1.0 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 |
0.1 |
GO:0090335 |
regulation of brown fat cell differentiation(GO:0090335) |
| 0.1 |
0.4 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 |
0.3 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
1.8 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.1 |
0.7 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.1 |
0.4 |
GO:1905034 |
regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
| 0.1 |
0.4 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.1 |
0.6 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.1 |
0.6 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
2.8 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
1.0 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.1 |
0.6 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.1 |
0.4 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.1 |
0.1 |
GO:0080144 |
amino acid homeostasis(GO:0080144) |
| 0.1 |
2.8 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.1 |
0.7 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.1 |
1.0 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
1.4 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
0.6 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.1 |
GO:0035384 |
thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
| 0.1 |
1.7 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
1.5 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.1 |
0.1 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.1 |
0.1 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 |
0.4 |
GO:1901355 |
response to rapamycin(GO:1901355) |
| 0.1 |
1.1 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.3 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.1 |
0.4 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.1 |
0.1 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.1 |
0.5 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.1 |
0.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.1 |
GO:0050994 |
regulation of lipid catabolic process(GO:0050994) |
| 0.1 |
0.3 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
0.5 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.4 |
GO:0045575 |
basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 0.1 |
0.5 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.1 |
0.7 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 |
2.5 |
GO:0098534 |
centriole replication(GO:0007099) centriole assembly(GO:0098534) |
| 0.1 |
0.4 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.1 |
0.7 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
0.7 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
1.4 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 |
0.8 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.1 |
0.7 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.1 |
0.4 |
GO:0070265 |
necrotic cell death(GO:0070265) |
| 0.1 |
0.4 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 |
0.6 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.1 |
0.4 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.1 |
0.6 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
1.9 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.1 |
2.1 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.4 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.1 |
1.0 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.4 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.4 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.1 |
0.1 |
GO:0061525 |
hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
| 0.1 |
0.5 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.6 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 |
1.3 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.1 |
0.4 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.4 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.4 |
GO:0003161 |
cardiac conduction system development(GO:0003161) |
| 0.1 |
0.5 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
1.3 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
0.2 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
1.2 |
GO:2000209 |
regulation of anoikis(GO:2000209) |
| 0.1 |
1.1 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
0.9 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
0.1 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.1 |
1.4 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.1 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
2.2 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
0.5 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.7 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.6 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.1 |
1.0 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 |
0.4 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.1 |
0.6 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.1 |
0.2 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 |
0.7 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
0.5 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.1 |
0.6 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.1 |
0.6 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.1 |
1.4 |
GO:0046838 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) |
| 0.1 |
0.2 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.4 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.2 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.1 |
0.5 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 |
1.1 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.1 |
0.4 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 |
0.2 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.1 |
0.9 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.1 |
0.8 |
GO:0098787 |
mRNA cleavage involved in mRNA processing(GO:0098787) |
| 0.1 |
0.1 |
GO:1900086 |
positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.1 |
0.5 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) small RNA loading onto RISC(GO:0070922) |
| 0.1 |
0.7 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 |
0.3 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 |
0.3 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.2 |
GO:1901072 |
glucosamine-containing compound catabolic process(GO:1901072) |
| 0.1 |
0.2 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.1 |
0.1 |
GO:0001710 |
mesodermal cell fate commitment(GO:0001710) |
| 0.1 |
1.0 |
GO:0046782 |
regulation of viral transcription(GO:0046782) |
| 0.1 |
0.5 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.1 |
1.4 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.1 |
1.4 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.1 |
0.2 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
1.2 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
| 0.1 |
0.3 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.1 |
0.3 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 |
0.6 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.3 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.1 |
0.4 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.3 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.1 |
0.4 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
0.2 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.1 |
0.3 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.1 |
0.1 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.8 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.1 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.1 |
0.8 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
0.4 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.3 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.1 |
0.1 |
GO:0001788 |
antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.1 |
2.9 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.1 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.1 |
0.2 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.1 |
0.2 |
GO:1902749 |
regulation of cell cycle G2/M phase transition(GO:1902749) |
| 0.1 |
0.3 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 |
0.8 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
1.1 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 |
0.6 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 |
0.4 |
GO:0060177 |
regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 |
0.1 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 0.1 |
0.2 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
0.2 |
GO:0032922 |
circadian regulation of gene expression(GO:0032922) |
| 0.1 |
0.2 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.1 |
0.2 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.1 |
1.0 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.1 |
1.7 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.1 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.1 |
0.6 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
1.5 |
GO:0006972 |
hyperosmotic response(GO:0006972) |
| 0.1 |
0.1 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
1.8 |
GO:2000147 |
positive regulation of cell motility(GO:2000147) |
| 0.1 |
0.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
0.4 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.1 |
0.2 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.2 |
GO:1900125 |
regulation of hyaluronan biosynthetic process(GO:1900125) negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
1.1 |
GO:0021889 |
olfactory bulb interneuron differentiation(GO:0021889) |
| 0.1 |
0.9 |
GO:0046512 |
sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
2.0 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.1 |
0.4 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.1 |
0.2 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
0.7 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.1 |
1.2 |
GO:0042044 |
fluid transport(GO:0042044) |
| 0.1 |
0.4 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.3 |
GO:2000643 |
positive regulation of vacuolar transport(GO:1903337) positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 |
0.2 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.1 |
0.2 |
GO:0015908 |
fatty acid transport(GO:0015908) |
| 0.1 |
0.4 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.1 |
0.2 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.1 |
0.5 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
0.4 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
0.1 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 |
0.5 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.3 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.1 |
0.6 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 |
0.3 |
GO:2000674 |
regulation of type B pancreatic cell apoptotic process(GO:2000674) |
| 0.1 |
0.1 |
GO:0032715 |
negative regulation of interleukin-6 production(GO:0032715) |
| 0.1 |
0.6 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.5 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
2.0 |
GO:0007140 |
male meiosis(GO:0007140) |
| 0.1 |
0.3 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
0.9 |
GO:0032048 |
cardiolipin metabolic process(GO:0032048) |
| 0.1 |
0.3 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.1 |
1.3 |
GO:0036295 |
cellular response to increased oxygen levels(GO:0036295) |
| 0.1 |
0.4 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.1 |
1.9 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) |
| 0.1 |
0.3 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.6 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
1.3 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
0.4 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
0.8 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 |
0.2 |
GO:1990000 |
amyloid fibril formation(GO:1990000) |
| 0.1 |
1.5 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
1.3 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.6 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.1 |
0.3 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.1 |
1.4 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.1 |
0.5 |
GO:0030330 |
DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 0.1 |
0.2 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.1 |
3.0 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.1 |
0.5 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.1 |
0.3 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.1 |
0.2 |
GO:0060167 |
regulation of adenosine receptor signaling pathway(GO:0060167) |
| 0.1 |
0.7 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
0.7 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.4 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.1 |
0.3 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.1 |
0.6 |
GO:0051461 |
corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.1 |
1.2 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.6 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 |
0.7 |
GO:1903332 |
regulation of protein folding(GO:1903332) |
| 0.1 |
0.4 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.1 |
0.5 |
GO:0071679 |
commissural neuron axon guidance(GO:0071679) |
| 0.1 |
0.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.2 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 |
0.4 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) inositol phosphate-mediated signaling(GO:0048016) |
| 0.1 |
0.4 |
GO:0010803 |
regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.1 |
0.9 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.1 |
0.5 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.1 |
0.3 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 |
1.3 |
GO:1903077 |
negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.1 |
0.7 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
0.8 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.3 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.3 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.1 |
0.8 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.1 |
0.3 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.1 |
0.7 |
GO:0000097 |
sulfur amino acid biosynthetic process(GO:0000097) |
| 0.1 |
1.2 |
GO:0001738 |
morphogenesis of a polarized epithelium(GO:0001738) |
| 0.1 |
0.3 |
GO:0060468 |
prevention of polyspermy(GO:0060468) |
| 0.1 |
0.3 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.1 |
0.1 |
GO:1903203 |
neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
| 0.1 |
0.3 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.1 |
0.2 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.1 |
0.3 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.1 |
0.1 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.1 |
1.5 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.5 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
| 0.1 |
0.8 |
GO:2000177 |
regulation of neural precursor cell proliferation(GO:2000177) |
| 0.1 |
1.6 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.1 |
0.1 |
GO:0009451 |
RNA modification(GO:0009451) |
| 0.1 |
0.3 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
0.3 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
0.9 |
GO:2000178 |
negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.1 |
0.2 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
0.6 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.1 |
1.4 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.1 |
3.0 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.2 |
GO:0032278 |
positive regulation of gonadotropin secretion(GO:0032278) |
| 0.1 |
0.7 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.1 |
0.1 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) |
| 0.1 |
0.1 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.1 |
0.2 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.1 |
0.2 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.1 |
0.7 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.1 |
0.6 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.1 |
0.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.1 |
0.3 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 |
0.2 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 |
1.7 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.1 |
0.3 |
GO:0072337 |
modified amino acid transport(GO:0072337) |
| 0.1 |
0.1 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 |
0.1 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.1 |
0.1 |
GO:0010458 |
exit from mitosis(GO:0010458) |
| 0.1 |
0.2 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.1 |
1.6 |
GO:0030071 |
regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
| 0.1 |
0.2 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
0.3 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.1 |
1.0 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
0.3 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.2 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.1 |
0.2 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 0.1 |
1.0 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.1 |
0.2 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.6 |
GO:0060055 |
angiogenesis involved in wound healing(GO:0060055) |
| 0.1 |
0.2 |
GO:0030240 |
skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
| 0.1 |
0.3 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.1 |
0.8 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.1 |
0.3 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
0.5 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.3 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.7 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
0.6 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.1 |
1.0 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 |
1.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
0.4 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.1 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.1 |
0.6 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.1 |
1.1 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.2 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.1 |
0.3 |
GO:0042053 |
regulation of dopamine metabolic process(GO:0042053) regulation of catecholamine metabolic process(GO:0042069) |
| 0.1 |
1.5 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.1 |
0.9 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.3 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 |
0.2 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.1 |
0.7 |
GO:0031507 |
heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
| 0.1 |
0.5 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.7 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 |
0.4 |
GO:0001541 |
ovarian follicle development(GO:0001541) |
| 0.1 |
0.4 |
GO:0033260 |
nuclear DNA replication(GO:0033260) |
| 0.1 |
0.2 |
GO:0002374 |
cytokine secretion involved in immune response(GO:0002374) regulation of cytokine secretion involved in immune response(GO:0002739) positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.1 |
0.1 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.1 |
0.4 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 |
0.4 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.1 |
0.4 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
0.5 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.1 |
0.1 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.1 |
0.3 |
GO:0086016 |
AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.1 |
0.1 |
GO:1900120 |
regulation of receptor binding(GO:1900120) |
| 0.1 |
0.3 |
GO:0046668 |
programmed cell death involved in cell development(GO:0010623) retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
| 0.1 |
0.1 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.1 |
0.2 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
1.2 |
GO:2000737 |
negative regulation of stem cell differentiation(GO:2000737) |
| 0.1 |
0.3 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.1 |
1.0 |
GO:0002716 |
negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.1 |
0.3 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
0.8 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 |
1.7 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.1 |
0.1 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.1 |
2.0 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.2 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.1 |
0.5 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.1 |
0.3 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.1 |
0.1 |
GO:0010226 |
response to lithium ion(GO:0010226) |
| 0.1 |
0.9 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.3 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.1 |
1.1 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.1 |
0.2 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.1 |
0.5 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.1 |
0.1 |
GO:2000544 |
cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
| 0.1 |
0.1 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.1 |
0.7 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.3 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) |
| 0.1 |
0.2 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 |
0.5 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
0.9 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
0.3 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.4 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.1 |
0.4 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.4 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.1 |
0.5 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.1 |
0.3 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.1 |
0.1 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 |
0.3 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 |
0.4 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.1 |
0.7 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.1 |
0.2 |
GO:0051496 |
positive regulation of stress fiber assembly(GO:0051496) |
| 0.1 |
0.2 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.1 |
0.5 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
0.1 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.1 |
0.7 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.4 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.1 |
0.1 |
GO:1903432 |
regulation of TORC1 signaling(GO:1903432) |
| 0.1 |
0.1 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
0.2 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.1 |
0.3 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
0.3 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.1 |
1.4 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.1 |
0.2 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.2 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
1.1 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.4 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.6 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
0.1 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.1 |
0.2 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.6 |
GO:0030011 |
maintenance of cell polarity(GO:0030011) |
| 0.1 |
0.1 |
GO:0009814 |
defense response, incompatible interaction(GO:0009814) |
| 0.1 |
0.2 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 |
0.1 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.1 |
0.5 |
GO:1904355 |
regulation of telomere capping(GO:1904353) positive regulation of telomere capping(GO:1904355) |
| 0.1 |
0.5 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
0.1 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 |
0.3 |
GO:0019682 |
glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
| 0.1 |
0.7 |
GO:0048538 |
thymus development(GO:0048538) |
| 0.1 |
0.1 |
GO:0006778 |
porphyrin-containing compound metabolic process(GO:0006778) |
| 0.1 |
0.2 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.1 |
0.3 |
GO:0048864 |
stem cell development(GO:0048864) |
| 0.1 |
0.2 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
| 0.1 |
0.1 |
GO:1903243 |
negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.1 |
0.1 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.1 |
1.0 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.1 |
0.6 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.1 |
0.1 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.1 |
2.0 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.1 |
0.3 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.1 |
0.2 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.1 |
0.4 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.1 |
0.2 |
GO:1904659 |
glucose transmembrane transport(GO:1904659) |
| 0.1 |
0.4 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.1 |
0.7 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
1.0 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
0.1 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 |
0.2 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.1 |
GO:1905077 |
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) negative regulation of interleukin-17 secretion(GO:1905077) |
| 0.1 |
0.1 |
GO:1990839 |
response to endothelin(GO:1990839) |
| 0.1 |
0.5 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.1 |
0.2 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
1.2 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.1 |
0.2 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.2 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.1 |
0.3 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.1 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.1 |
2.1 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
0.4 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.1 |
0.2 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.1 |
0.1 |
GO:0060253 |
negative regulation of Schwann cell proliferation(GO:0010626) negative regulation of glial cell proliferation(GO:0060253) |
| 0.1 |
0.2 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.1 |
0.4 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.2 |
GO:0046032 |
ADP catabolic process(GO:0046032) IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 |
0.2 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
| 0.1 |
1.1 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
1.8 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.1 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.1 |
0.5 |
GO:0034113 |
heterotypic cell-cell adhesion(GO:0034113) |
| 0.0 |
0.1 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.0 |
0.1 |
GO:0010641 |
positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.0 |
0.1 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.0 |
0.1 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 |
0.0 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.0 |
0.6 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.4 |
GO:0006573 |
valine metabolic process(GO:0006573) |
| 0.0 |
0.1 |
GO:0086069 |
bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.0 |
0.2 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.5 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.0 |
0.2 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.0 |
0.1 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.0 |
0.3 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 |
4.2 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.3 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.0 |
0.0 |
GO:0042559 |
pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.0 |
0.2 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.0 |
0.2 |
GO:0006303 |
double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.0 |
0.1 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.0 |
0.2 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.0 |
0.4 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 |
0.0 |
GO:0097242 |
beta-amyloid clearance(GO:0097242) regulation of beta-amyloid clearance(GO:1900221) |
| 0.0 |
0.2 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 |
3.3 |
GO:0016125 |
sterol metabolic process(GO:0016125) |
| 0.0 |
0.1 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.0 |
0.0 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.0 |
0.1 |
GO:0034035 |
sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 |
0.0 |
GO:1903719 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.0 |
0.9 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.4 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 |
0.1 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.2 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.1 |
GO:1902065 |
response to L-glutamate(GO:1902065) |
| 0.0 |
0.2 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.0 |
0.2 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 |
0.1 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.0 |
0.3 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.0 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.0 |
0.2 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.0 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.0 |
1.0 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.1 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.0 |
0.2 |
GO:0072584 |
caveolin-mediated endocytosis(GO:0072584) |
| 0.0 |
0.1 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.0 |
0.1 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.0 |
0.1 |
GO:0051180 |
vitamin transport(GO:0051180) |
| 0.0 |
0.3 |
GO:0010470 |
regulation of gastrulation(GO:0010470) |
| 0.0 |
0.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.0 |
0.2 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.2 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.0 |
0.3 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.0 |
0.1 |
GO:0060479 |
lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
| 0.0 |
0.7 |
GO:0051291 |
protein heterooligomerization(GO:0051291) |
| 0.0 |
0.7 |
GO:2000045 |
regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
| 0.0 |
0.3 |
GO:0098885 |
modification of postsynaptic actin cytoskeleton(GO:0098885) |
| 0.0 |
0.3 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.0 |
0.1 |
GO:2000192 |
negative regulation of fatty acid transport(GO:2000192) |
| 0.0 |
0.3 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.0 |
0.7 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.0 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.0 |
0.2 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.0 |
0.3 |
GO:0036037 |
CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.0 |
GO:0061339 |
establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.0 |
0.9 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
0.4 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.0 |
0.1 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.0 |
0.4 |
GO:0001890 |
placenta development(GO:0001890) |
| 0.0 |
0.1 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.0 |
0.0 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.0 |
0.4 |
GO:0060324 |
face development(GO:0060324) |
| 0.0 |
0.2 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.0 |
0.1 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.0 |
0.0 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) demethylation(GO:0070988) |
| 0.0 |
0.1 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.3 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.0 |
0.6 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.1 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.0 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.0 |
0.2 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.4 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.4 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.1 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.0 |
0.2 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.0 |
0.0 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.1 |
GO:0031056 |
regulation of histone modification(GO:0031056) |
| 0.0 |
0.2 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.0 |
0.1 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.0 |
0.1 |
GO:0090103 |
cochlea morphogenesis(GO:0090103) |
| 0.0 |
0.1 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.3 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.1 |
GO:0031652 |
positive regulation of heat generation(GO:0031652) |
| 0.0 |
0.4 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.0 |
0.2 |
GO:0051930 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.0 |
0.4 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.0 |
0.2 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.1 |
GO:0060534 |
trachea cartilage development(GO:0060534) |
| 0.0 |
0.3 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.0 |
0.3 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.0 |
0.2 |
GO:0001773 |
myeloid dendritic cell activation(GO:0001773) |
| 0.0 |
0.1 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.0 |
0.0 |
GO:0010869 |
regulation of receptor biosynthetic process(GO:0010869) |
| 0.0 |
0.4 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.0 |
0.1 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.0 |
0.3 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.0 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.0 |
0.2 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.1 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.0 |
0.1 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.0 |
0.2 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 |
0.1 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.1 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.0 |
0.0 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 |
0.4 |
GO:0006006 |
glucose metabolic process(GO:0006006) |
| 0.0 |
0.3 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
1.4 |
GO:0005976 |
polysaccharide metabolic process(GO:0005976) |
| 0.0 |
0.1 |
GO:0072575 |
hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
| 0.0 |
0.1 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.0 |
0.1 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 |
0.2 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.0 |
0.1 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) |
| 0.0 |
0.2 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.0 |
1.8 |
GO:0006821 |
chloride transport(GO:0006821) |
| 0.0 |
0.2 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.0 |
0.3 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 |
0.1 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.0 |
0.1 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 |
0.1 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.0 |
0.1 |
GO:0016525 |
negative regulation of angiogenesis(GO:0016525) |
| 0.0 |
0.1 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.0 |
0.1 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.1 |
GO:0046364 |
hexose biosynthetic process(GO:0019319) monosaccharide biosynthetic process(GO:0046364) |
| 0.0 |
0.1 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.0 |
0.3 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.0 |
0.9 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
1.5 |
GO:0031497 |
chromatin assembly(GO:0031497) |
| 0.0 |
0.0 |
GO:0048339 |
paraxial mesoderm development(GO:0048339) |
| 0.0 |
0.1 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.0 |
0.4 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.0 |
0.1 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 |
0.4 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.0 |
0.2 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.0 |
0.1 |
GO:0032196 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 0.0 |
0.0 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.0 |
0.0 |
GO:0001825 |
blastocyst formation(GO:0001825) |
| 0.0 |
0.2 |
GO:0090559 |
regulation of membrane permeability(GO:0090559) |
| 0.0 |
0.2 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.0 |
0.3 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.0 |
0.0 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.1 |
GO:0015865 |
purine nucleotide transport(GO:0015865) |
| 0.0 |
0.2 |
GO:0045005 |
DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.0 |
0.0 |
GO:0060192 |
negative regulation of lipase activity(GO:0060192) |
| 0.0 |
0.2 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.0 |
0.0 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.0 |
0.0 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 0.0 |
0.1 |
GO:0044364 |
killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 |
0.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.0 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.0 |
0.6 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.0 |
0.1 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.0 |
0.1 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.0 |
GO:0046620 |
regulation of organ growth(GO:0046620) |
| 0.0 |
0.0 |
GO:0035357 |
peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.0 |
0.1 |
GO:0006661 |
phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.0 |
0.0 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
0.1 |
GO:2000109 |
macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.0 |
0.4 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.2 |
GO:0035315 |
hair cell differentiation(GO:0035315) |
| 0.0 |
0.1 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.0 |
0.1 |
GO:0045852 |
pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.0 |
0.0 |
GO:0072191 |
ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
| 0.0 |
0.3 |
GO:0007044 |
cell-substrate junction assembly(GO:0007044) |
| 0.0 |
0.1 |
GO:2001169 |
regulation of ATP biosynthetic process(GO:2001169) |
| 0.0 |
0.1 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.0 |
0.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.0 |
0.1 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.0 |
0.0 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) cellular response to growth hormone stimulus(GO:0071378) |
| 0.0 |
0.1 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 |
0.0 |
GO:0048687 |
positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 0.0 |
0.1 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.2 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.0 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.0 |
0.1 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
0.0 |
GO:0051150 |
regulation of smooth muscle cell differentiation(GO:0051150) |
| 0.0 |
0.2 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.0 |
0.1 |
GO:0045954 |
positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.0 |
0.0 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.0 |
0.0 |
GO:0038202 |
TORC1 signaling(GO:0038202) |
| 0.0 |
0.1 |
GO:0002861 |
regulation of inflammatory response to antigenic stimulus(GO:0002861) |
| 0.0 |
0.0 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.1 |
GO:0001667 |
ameboidal-type cell migration(GO:0001667) |
| 0.0 |
0.0 |
GO:1990748 |
cellular detoxification(GO:1990748) |
| 0.0 |
0.1 |
GO:0047497 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.0 |
0.1 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.1 |
GO:0060760 |
positive regulation of response to cytokine stimulus(GO:0060760) |
| 0.0 |
0.0 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.0 |
0.3 |
GO:0048747 |
muscle fiber development(GO:0048747) |
| 0.0 |
0.2 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.0 |
0.0 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.0 |
0.0 |
GO:0019730 |
antimicrobial humoral response(GO:0019730) |
| 0.0 |
0.0 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.0 |
0.1 |
GO:1903901 |
negative regulation of viral life cycle(GO:1903901) |
| 0.0 |
0.1 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.0 |
0.0 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.0 |
0.0 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.0 |
0.0 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.0 |
0.1 |
GO:1904738 |
vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.0 |
0.1 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.0 |
0.0 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.0 |
GO:0006681 |
galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.0 |
0.1 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.0 |
0.0 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.0 |
0.0 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.0 |
0.0 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
